Nadolol Versus Propranolol in Children With Infantile Hemangiomas

Status Completed

Clinical Trial Summary

The purpose of this study is to assess the efficacy and safety of oral propranolol versus nadolol in patients with Infantile Hemangiomas (IH) in a randomized, controlled, double-blinded study.

Clinical Trial Description

The study objective is to compare the efficacy and safety of oral propranolol in comparison with oral nadolol in patients with IH. Patients will be randomly assigned to either propranolol or dose equivalent nadolol. The duration of the study will be 24 weeks, however, patient will be monitored for up to 1 year post study enrolment. Both efficacy and safety will be closely monitored and captured. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02505971
Study type	Interventional
Source	The Hospital for Sick Children
Contact
Status	Completed
Phase	Phase 3
Start date	September 2015
Completion date	June 30, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04288700` - Evaluation of the Efficacy of Captopril Versus Propranolol and Timolol as a Treatment of Infantile Capillary Hemangioma	Phase 4
Completed	`NCT01431326` - Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Completed	`NCT01010308` - Nadolol for Proliferating Infantile Hemangiomas	Phase 2
Completed	`NCT02913612` - Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH)	Phase 2
Completed	`NCT01673971` - Optical Tomographic Imaging of Infantile Hemangiomas
Recruiting	`NCT03237637` - Comparative Study to Evaluate the Effectiveness of Atenolol and Propranolol in the Treatment of Infantile Hemangiomas	Phase 3
Recruiting	`NCT05479123` - Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas	Phase 4
Terminated	`NCT01434849` - Timolol for the Prevention of Proliferation of Infantile Hemangioma (TiPPIH Trial)	Phase 1
Completed	`NCT04105517` - Hemangiol, Post Marketing Surveillance Study
Completed	`NCT01512173` - Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to Placebo	Phase 2
Completed	`NCT01056341` - Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy	Phase 2/Phase 3
Not yet recruiting	`NCT04684667` - ''Efficacy of Propranolol in the Treatment of Infantile Hemangioma"	Phase 2
Recruiting	`NCT03842631` - Optimizing Timolol Maleate Treatment of Infantile Hemangioma by Doppler Ultrasound Examination
Recruiting	`NCT03173352` - A Prospective Study on the Incidence and Related Risk Factors of Infantile Hemangioma in China	N/A